Determinants of success of a stance-control-KAFO in former polio patients with quadriceps weakness.

Determinants of success of a stance-control-KAFO in former polio patients with quadriceps weakness. - The effect of the stance-control KAFO on walking.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30315

Enrollment

Registered

2006-09-12

Start date

2006-09-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

late effects of poliomyelitis post-polio syndrome

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Diagnosis of poliomyelitis, 2) prescribed with a stance-control_KAFO, 3) ability to walk 6 minutes, 4) age 18-70

Exclusion criteria

Exclusion criteria: Co-morbidid disease that limits physical exercise tolerance or limits the patient in visiting the hospital to participate in the study protocol.

Design outcomes

Primary

Measure	Time frame
Succesful use of the prescribed SC-KAFO in daily life.	—

Secondary

Measure	Time frame
1) The primary outcome is energy expenditure of walking: Energy cost (O2/kg/meter) and oxygen uptake (O2/kg/min). 2) Spatio-temporal paramters of gait (velocity, cadence, step length, stride length) 3) Kinematic and kinetic parameters of gait (joint angles and moments of the ankle, knee and hip joint) 4) Muscle strength of the knie flexors and extensors 5) Comfort and experienced functioning with the prescribed SC-KAVO 6) Health related quality of life	—

Measure

Time frame

1) The primary outcome is energy expenditure of walking: Energy cost (O2/kg/meter) and oxygen uptake (O2/kg/min). 2) Spatio-temporal paramters of gait (velocity, cadence, step length, stride length) 3) Kinematic and kinetic parameters of gait (joint angles and moments of the ankle, knee and hip joint) 4) Muscle strength of the knie flexors and extensors 5) Comfort and experienced functioning with the prescribed SC-KAVO 6) Health related quality of life

—

Countries

Netherlands

Outcome results